| |
|
|
|
Arcus Biosciences Inc.  
|
|
8.44 0.03 (0%) |
10-18 16:02 |
|
Open: |
8.4 |
Pre close: |
8.41 |
Target:
|
10.76
|
|
High: |
8.5 |
Low: |
8.13 |
Resistance:
|
9.22
10.34
|
|
Volume: |
175,057 |
Market Cap: |
387M |
Support:
|
7.40
6.16
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.21
 |
MACD |
MACD(12,26):
|
-0.06 |
|
MA(20): |
8.54  |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
8.16 |
Stochastic Oscillator |
%K(14,3):
|
31.96 |
|
MA(250): |
9.84 |
%D(3): |
27.14 |
|
Average Volume(K) |
3-Month: |
23844
|
52-Week |
High:
|
13.77 |
|
10-Days: |
33017 |
Low: |
6.30 |
|
RSI |
RSI(14):
|
50.93 |
Change(%): |
-28.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.590 |
Return on Equity (ttm) |
-30.5 |
Shares Out. (M) |
45.85 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-17.3 |
Shares Float (M) |
25.32 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
20.39 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
40.0 |
% Held by Institutions |
50.07 |
|
Forward EPS |
-1.849 |
Gross Profit (p.s.) |
-0.901 |
Shares Short (K) |
1540 |
|
Book Value (p.s.) |
4.480 |
EBITDA (p.s.) |
-1.522 |
P/E |
-5.31 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.88 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-55.46 |
P/S |
1758972672.00 |
|
Operating Margin |
-786.49 |
Levered Free Cash Flow
(M) |
-30.34 |
P/CF |
-6.98 |
|
|
|
|
|
|
